United Therapeutics Corporation Reports Second Quarter 2013 Financial Results

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SILVER SPRING, Md., July 25, 2013 -- SILVER SPRING, Md., July 25, 2013 /PRNewswire/ --

  • Total Revenues of $280.6 million
  • Earnings per Share of $1.60 per Basic Share or $1.52 per Diluted Share
  • Earnings Before Non-Cash Charges of $3.29 per Basic Share, or $3.11 per Diluted Share

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC